The induction of broadly neutralizing antibodies (bNAbs) is a serious aim in vaccine analysis. HIV-1 contaminated people that develop exceptionally robust bNAb responses, termed elite neutralizers, can inform vaccine design by offering blueprints for the induction of comparable bNAb responses.
